Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-17
1994-10-18
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544263, 544281, A61K 31505, C07D48704
Patent
active
053568974
ABSTRACT:
This invention relates to heterocyclic derivatives useful for inhibiting the production of Interleukin-1 (IL-1) and tumor necrosis factor (TNF) and the like, which can be represented by the following formula: ##STR1## to a process for their production, to a pharmaceutical composition containing the same and to uses thereof.
REFERENCES:
Bellec et al, "Canadian J. Chem." vol. 59, pp. 2826-2832, 1981.
Abe Yoshito
Kawai Yoshio
Marusawa Hiroshi
Oku Teruo
Tanaka Hirokazu
Drehkoff W. Dennis
Fujisawa Pharmaceutical Co. Ltd.
Gupta Y. N.
Shah Mukund J.
LandOfFree
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2372618